FDA Okays Onzetra Xsail Intranasal Migraine Medication FDA Okays Onzetra Xsail Intranasal Migraine Medication

The product, a low-dose sumatriptan powder delivered intranasally, promises to provide targeted and efficient delivery with the potential for 'fast, consistent relief.' FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news